Related Experiment Video
Updated: Apr 17, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Cyclic adenosine monophosphate protects renal cell lines against amphotericin B toxicity in a PKA-independent manner
A F Ferreira1, F D França1, J V Rossoni2
1a Departamento de Bioquímica e Imunologia , Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais , Belo Horizonte , MG , Brazil .
Abstract:
Amphotericin B is the "gold standard" agent in the management of serious systemic fungal infections. However, this drug can cause nephrotoxicity, which contributes up to 25% of all acute kidney injuries in critically ill patients. Cyclic adenosine monophosphate can protect kidney cells from death due to injury or drug exposure in some cases. Hence, the objective of this work was to evaluate if cAMP could prevent cell death that occurs in renal cell lines subjected to AmB treatment and, if so, to assess the involvement of PKA in the transduction of this signal. Two different renal cell lines (LLC-PK1 and MDCK) were used in this study. MTT and flow cytometry assays showed increased cell survival when cells were exposed to cAMP in a PKA-independent manner, which was confirmed by western blot. This finding suggests that cAMP (db-cAMP) may prevent cell death caused by exposure to AmB. This is the first time this effect has been identified when renal cells are exposed to AmB's nephrotoxic potential.
Insights
Cyclic adenosine monophosphate (cAMP) protects kidney cells from Amphotericin B-induced toxicity. This study found that cAMP prevents renal cell death independently of protein kinase A (PKA), offering a novel protective strategy.
Area of Science:
- Nephrology
- Pharmacology
- Cell Biology
Background:
- Amphotericin B (AmB) is crucial for treating systemic fungal infections but causes significant nephrotoxicity.
- This drug-induced kidney injury contributes to a substantial portion of acute kidney injuries in critical care settings.
- Cyclic adenosine monophosphate (cAMP) has demonstrated protective effects on kidney cells against various injuries.
Purpose of the Study:
- To investigate the potential of cAMP in preventing Amphotericin B-induced cell death in renal cell lines.
- To determine the involvement of protein kinase A (PKA) in the protective signaling pathway of cAMP against AmB toxicity.
Main Methods:
- Utilized two distinct renal cell lines: LLC-PK1 and MDCK.
- Employed MTT and flow cytometry assays to assess cell viability and survival rates.
- Confirmed signaling pathways using western blot analysis.
Main Results:
- Exposure to cAMP significantly increased cell survival in renal cell lines treated with Amphotericin B.
- The protective effect of cAMP was observed to be independent of protein kinase A (PKA) activation.
- Western blot analysis corroborated the PKA-independent nature of the observed protection.
Conclusions:
- Cyclic adenosine monophosphate (db-cAMP) demonstrates a protective effect against Amphotericin B-induced nephrotoxicity in renal cell lines.
- This protective mechanism operates independently of the protein kinase A (PKA) signaling pathway.
- This represents a novel finding in understanding the potential therapeutic strategies against AmB-related kidney injury.
More Related Videos
06:32Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
Related Concept Videos
Antifungal Agents
Inhibitors of Bacterial Protein Synthesis
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Inhibition of Cdk Activity
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...